Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Moodys
Baxter
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072344

See Plans and Pricing

« Back to Dashboard

NDA 072344 describes ACEPHEN, which is a drug marketed by Acp Nimble and is included in four NDAs. It is available from three suppliers. Additional details are available on the ACEPHEN profile page.

The generic ingredient in ACEPHEN is acetaminophen. There are sixty-six drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
Summary for 072344
Tradename:ACEPHEN
Applicant:Acp Nimble
Ingredient:acetaminophen
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 072344
Suppliers and Packaging for NDA: 072344
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072344 ANDA Cosette Pharmaceuticals, Inc. 0713-0164 0713-0164-01 100 BLISTER PACK in 1 BOX (0713-0164-01) > 1 SUPPOSITORY in 1 BLISTER PACK
ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072344 ANDA Cosette Pharmaceuticals, Inc. 0713-0164 0713-0164-12 12 BLISTER PACK in 1 BOX (0713-0164-12) > 1 SUPPOSITORY in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SUPPOSITORY;RECTALStrength325MG
Approval Date:Mar 27, 1992TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
Baxter
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.